Earnings Per Share, Basic in USD/shares of LIGAND PHARMACEUTICALS INC from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from 2011 to Q3 2025.
  • Ligand Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending September 30, 2025 was 5.99 USD/shares.
  • Ligand Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 2 USD/shares, a 14.9% decline year-over-year.
  • Ligand Pharmaceuticals Inc annual Earnings Per Share, Basic for 2024 was -0.22 USD/shares, a 107% decline from 2023.
  • Ligand Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was 3.02 USD/shares.
  • Ligand Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -1.98 USD/shares, a 158% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

LIGAND PHARMACEUTICALS INC Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.00 $5.99 +$6.38 Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 -$4 $0.25 +$3.13 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 -$7 -$2 -$7 -145% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $0 -$2 -$3 -277% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 $2.00 $0 +$0.20 +33.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 $2.00 -$3 -$3 -2315% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 $5.00 $4.86 +$2.40 +97.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 $3.00 $1.02 +$2.06 Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 $0 -$1 -$1 -3050% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.00 $0.13 +$0.18 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.00 $2.46 +$3.37 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$1 -$1 -$1 -225% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 -$1 $0.02 -$1 -97.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 $0 -$2 -103% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.00 -$1 -$2 -183% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $3.00 $0 -$1 -189% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $4.00 $0.82 +$1.24 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.00 $1.84 +$0.46 +33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.00 $1.10 +$2.56 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $0 $0.36 +$0.79 Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 $0 $0 +$0.39 +48.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$1 $1.38 +$2.12 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$3 -$1 -$34 -104% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $30.00 $0 +$1.59 +78.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $29.00 -$1 -$4 -125% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 $33.00 -$1 -$4 -121% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 $37.00 $32.60 +$30.50 +1430% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 $6.00 -$2 $0 0% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $6.00 $3.19 $0 0% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $6.00 $3.45 $0 0% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $6.00 $2.13 $0 0% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $6.00 -$2 -$2 -1447% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $8.00 $3.19 +$3.14 +6280% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $5.00 $3.45 +$3.75 Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 $2.00 $2.13 +$1.81 +566% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 $0 $0.15 $0 -53.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $0 $0.05 -$10 -99.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 $10.00 $0 -$1 -125% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $11.00 $0.32 +$0.28 +700% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $11.00 $0.32 $0 -8.57% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 $11.00 $10.00 +$9.95 +16583% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 $1.00 $1.19 +$1.11 +1388% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 $0 $0.04 $0 -60% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 $0 $0.35 +$0.26 +289% Oct 1, 2014 Dec 31, 2014 10-K 2016-11-14
Q3 2014 $0 $0.06 $0 -40% Jul 1, 2014 Sep 30, 2014 10-K 2016-11-14
Q2 2014 $0 $0.08 $0 -73.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-11-14
Q1 2014 $0 $0.10 +$0.03 +42.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-11-14
Q4 2013 $0 $0.09 Oct 1, 2013 Dec 31, 2013 10-K 2015-02-23
Q3 2013 $0.10 +$0.11 Jul 1, 2013 Sep 30, 2013 10-K 2015-02-23
Q2 2013 $0.30 +$0.43 Apr 1, 2013 Jun 30, 2013 10-K 2015-02-23
Q1 2013 $0.07 Jan 1, 2013 Mar 31, 2013 10-K 2015-02-23
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01

LIGAND PHARMACEUTICALS INC Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 -$3 -107% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $3.02 +$5.00 Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 -$2 -$5 -158% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 $3.44 +$3.62 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $0 -$33 -101% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $33.10 +$26.40 +389% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.77 +$6.17 +1028% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $0.60 +$0.68 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $0 -$12 -101% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $11.60 +$11.00 +1868% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $0.59 +$0.03 +5.36% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $0.56 +$0.59 Jan 1, 2013 Dec 31, 2013 10-K 2016-11-14
2012 $0 -$1 -106% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
2011 $0.49 Jan 1, 2011 Dec 31, 2011 10-K/A 2014-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.